UK NICE Elevates SGLT2 Inhibitors in Diabetes Guidance UK NICE Elevates SGLT2 Inhibitors in Diabetes Guidance

The sodium-glucose cotransporter 2 (SGLT2) inhibitor class is now listed clearly as a second-line option after metformin in type 2 diabetes.Heartwire from Medscape
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Diabetes & Endocrinology News Source Type: news